期刊
HUMAN MOLECULAR GENETICS
卷 19, 期 13, 页码 2616-2629出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddq149
关键词
-
资金
- FRSQ
- CIHR
- Canada Research Chair
Mutations in the gene encoding for the neurofilament light subunit (NF-L) are responsible for Charcot-Marie-Tooth (CMT) neuropathy type 2E. To address whether CMT2E disease is potentially reversible, we generated a mouse model with conditional doxycycline-responsive gene system that allows repression of mutant hNF-L-P22S transgene expression in adult neurons. The hNF-L-P22S;tTa transgenic (tg) mice recapitulated key features of CMT2E disease, including aberrant hindlimb posture, motor deficits, hypertrophy of muscle fibres and loss of muscle innervation without neuronal loss. Remarkably, a 3-month treatment of hNF-L-P22S; tTa mice with doxycycline after onset of disease efficiently down-regulated expression of hNF-L-P22S and it caused reversal of CMT neurological phenotypes with restoration of muscle innervation and of neurofilament protein distribution along the sciatic nerve. These data suggest that therapeutic approaches aimed at abolishing expression or neutralizing hNF-L mutants might not only halt the progress of CMT2E disease, but also revert the disabilities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据